Ependymoma
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Ependymoma

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Ependymoma Local Doctors?
Elite in Ependymoma
Elite in Ependymoma

Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville

10753 Falls Road, Pavilion II, Suite 115, Pavilion II, Suite 115, 
Lutherville, MD 
Languages Spoken:
English, Kannada
Offers Telehealth

Chetan Bettegowda is the director of the Johns Hopkins Department of Neurosurgery. He offers comprehensive treatments for adult patients with benign and malignant brain tumors, specializing in the treatment of patients with primary brain tumors such as gliomas, meningiomas and pituitary tumors. He performs both open surgery and stereotactic radiosurgery for patients with metastatic tumors to the brain, and also provides stereotactic radiosurgery for other neurological disorders, including spinal tumors, trigeminal neuralgia and skull-base tumors. Dr. Bettegowda is rated as an Elite provider by MediFind in the treatment of Ependymoma. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Trigeminal Neuralgia, Astrocytoma, Glioblastoma, Rhizotomy, and Microvascular Decompression. Dr. Bettegowda is board certified in American Board Of Neurological Surgery.

Distinguished in Ependymoma
Psychiatry | Neurology
Distinguished in Ependymoma
Psychiatry | Neurology

Advocate Medical Group Neurosurgery

3551 Highland Ave Ste, Ste 200A, 
Downers Grove, IL 
Languages Spoken:
English

Nina Paleologos is a Psychiatrist and a Neurologist practicing medicine in Downers Grove, Illinois. Dr. Paleologos is rated as a Distinguished provider by MediFind in the treatment of Ependymoma. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Oligodendroglioma, Glioma, Glioblastoma, and Astrocytoma. Dr. Paleologos is board certified in American Board Of Psychiatry & Neurology.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Ependymoma
Distinguished in Ependymoma

Carolinas Medical Center

1000 Blythe Blvd., 
Charlotte, NC 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Anthony Asher is a Neurosurgery provider practicing medicine in Charlotte, North Carolina. Dr. Asher is rated as a Distinguished provider by MediFind in the treatment of Ependymoma. He is also highly rated in 37 other conditions, according to our data. His clinical expertise encompasses Spondylolisthesis, Cervical Myelopathy, Brain Tumor, Laminectomy, and Spinal Fusion. Dr. Asher is board certified in American Board Of Neurological Surgery. Dr. Asher is currently accepting new patients.

What are the latest Ependymoma Clinical Trials?
A Pilot Feasibility and Efficacy (Phase 2) Trial of Real Time Drug Screening and Genomic Testing to Determine an Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma

Summary: The current study will use a new treatment approach based on the molecular characteristics of each participant's tumor. The study will test the feasibility in the pilot phase of performing real-time drug screening on tissue taken during surgery in patients with relapsed medulloblastoma or ependymoma and of having a specialized tumor board assign a treatment plan based on the results of this screen...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Prospective Natural History Study of Patients With Neurofibromatosis Type 2 (NF2).

Summary: Objective With this prospective natural experiment trial on neurofibromatosis type 2 (NF2) study, we hope to understand the factors leading to tumor progression and neurological disease burden in NF2. Study Population A total of 269 participants, ages 8-75, with a clinical or genetic diagnosis of NF2 will participate in this study. Design Study participants will be evaluated with a thorough physic...